These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17167701)

  • 1. The South African Hypertension Guideline 2006 is evidence-based but not cost-effective.
    Gaziano TA
    S Afr Med J; 2006 Nov; 96(11):1170-3. PubMed ID: 17167701
    [No Abstract]   [Full Text] [Related]  

  • 2. The South African Hypertension Guideline 2006 is evidence-based and not cost-effective--a rebuttal.
    Rayner BL; Seedat YK; Milne J; Pinkney-Atkinson V; Veriava Y
    S Afr Med J; 2007 Mar; 97(3):152, 154. PubMed ID: 17440654
    [No Abstract]   [Full Text] [Related]  

  • 3. Rationale for the hypertension guidelines for primary care in South Africa.
    Opie LH; Steyn K
    S Afr Med J; 1995 Dec; 85(12 Pt 2):1325-8, 1330-1, 1334-5 passim. PubMed ID: 8600605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for the management of hypertension at primary health care level. Hypertension Society of Southern Africa, endorsed by the Medical Association of South Africa and the Medical Research Council.
    S Afr Med J; 1995 Dec; 85(12 Pt 2):1321-5. PubMed ID: 8600604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in medical expenditure according to drug prices.
    Ueshima H
    Hypertens Res; 2006 May; 29(5):301-2. PubMed ID: 16832148
    [No Abstract]   [Full Text] [Related]  

  • 6. The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.
    Kok L; Engelfriet P; Jacobs-van der Bruggen MA; Hoogenveen RT; Boshuizen HC; Verschuren MW
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):371-6. PubMed ID: 19305351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SA Hypertension Guidelines set minimum standards for medical aid schemes.
    Cardiovasc J S Afr; 2006; 17(4):218-9. PubMed ID: 17001432
    [No Abstract]   [Full Text] [Related]  

  • 8. Guidelines for antihypertensive therapy: problems with a strategy based on absolute cardiovascular risk, reply to comments.
    Simpson FO
    J Hypertens; 1997 Jan; 15(1):1-2. PubMed ID: 9050964
    [No Abstract]   [Full Text] [Related]  

  • 9. The mild hypertension dilemma: results of the British MRC trial.
    Miall WE
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):12S-21S. PubMed ID: 3098929
    [No Abstract]   [Full Text] [Related]  

  • 10. [WHO/ISH 2003].
    Takeda K
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():556-61. PubMed ID: 16981590
    [No Abstract]   [Full Text] [Related]  

  • 11. Improving cost-effectiveness of hypertension management at a community health centre.
    Edwards PR; Lunt DW; Fehrsen GS; Lombard CJ; Steyn K
    S Afr Med J; 1998 May; 88(5):549-54. PubMed ID: 9638122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacoeconomic issues in antihypertensive treatment].
    Saito I
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():271-5. PubMed ID: 16981554
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level.
    Gaziano TA; Steyn K; Cohen DJ; Weinstein MC; Opie LH
    Circulation; 2005 Dec; 112(23):3569-76. PubMed ID: 16330698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling systolic hypertension effectively and economically.
    Nickey WA
    J Am Osteopath Assoc; 1991 Oct; 91(10):951, 955. PubMed ID: 1748582
    [No Abstract]   [Full Text] [Related]  

  • 15. [New treatment strategies for the management of hypertension].
    Reinhardt A; Linsel-Nitschke P; Schunkert H
    MMW Fortschr Med; 2009 Nov; 151(46):33-6. PubMed ID: 20043391
    [No Abstract]   [Full Text] [Related]  

  • 16. [The basic treatment of arterial hypertension (II). Pharmacological treatment].
    Pascual J; Orte L; Ortuño J
    Med Clin (Barc); 1994 Nov; 103(18):699-707. PubMed ID: 7808078
    [No Abstract]   [Full Text] [Related]  

  • 17. Left ventricular hypertrophy and clinical outcomes in hypertensive patients.
    Ruilope LM; Schmieder RE
    Am J Hypertens; 2008 May; 21(5):500-8. PubMed ID: 18437140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of antihypertensive drugs: a perspective on medical innovation.
    Cutler DM; Long G; Berndt ER; Royer J; Fournier AA; Sasser A; Cremieux P
    Health Aff (Millwood); 2007; 26(1):97-110. PubMed ID: 17211019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to lower treatment BP targets for hypertension?
    Carlberg B
    Lancet; 2009 Aug; 374(9689):503-4. PubMed ID: 19683626
    [No Abstract]   [Full Text] [Related]  

  • 20. [German Hypertension League update. What does the ALLHAT Study really mean?].
    MMW Fortschr Med; 2003 Jun; 145(23):45-6. PubMed ID: 12854226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.